BIOLASE INC (BIOL)

US0909117022 - Common Stock

0.1436  0 (-1.1%)

After market: 0.1516 +0.01 (+5.57%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

BIOLASE INC

NASDAQ:BIOL (6/14/2024, 7:00:01 PM)

After market: 0.1516 +0.01 (+5.57%)

0.1436

0 (-1.1%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month-87.4%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap4.79M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

BIOL Daily chart

Company Profile

BIOLASE Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Foothill Ranch, California and currently employs 188 full-time employees. BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft tissue) systems. The Waterlase brand uses a combination of water and laser energy and performs using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The firm also offers diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company also manufactures and sells consumable products and accessories for its laser systems. Its Waterlase and diode systems use disposable laser tips of differing sizes and shapes.

Company Info

BIOLASE INC

27042 Towne Centre Drive, Suite 270

Foothill Ranch CALIFORNIA 92610

P: 19493611200

CEO: John R. Beaver

Employees: 188

Website: https://www.biolase.com/

BIOL News

News Imagea month ago - InvestorPlaceBIOL Stock Earnings: Biolase Misses EPS, Beats Revenue for Q1 2024

BIOL stock results show that Biolase missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

News Imagea month ago - BusinessInsiderBIOL Stock Earnings: Biolase Misses EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biolase (NASDAQ:BIOL) just reported results for the first quarter of 2024.Biola...

News Image3 months ago - InvestorPlaceBIOL Stock Earnings: Biolase Beats EPS, Misses Revenue for Q4 2023

BIOL stock results show that Biolase beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

News Image3 months ago - BusinessInsiderBIOL Stock Earnings: Biolase Beats EPS, Misses Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biolase (NASDAQ:BIOL) just reported results for the fourth quarter of 2023.Biol...

BIOL Twits

Here you can normally see the latest stock twits on BIOL, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example